Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oral Vaccines
Biotech
Vaxart seeks answers as BARDA vaccine funding dries up again
Vaxart is actively seeking more information about why it was told to stop work under a federally funded COVID-19 vaccine contract.
Nick Paul Taylor
Aug 12, 2025 5:08am
Vaccine-probiotic combo clears gut infections in mice
Apr 9, 2025 5:25am
Researchers test under the tongue COVID vaccine in primates
Sep 13, 2023 1:38pm
Vaxart norovirus vaccine has mixed success in midphase test
Sep 7, 2023 5:31am
Vaxart's oral norovirus vax spurs immune response in ph. 2 trial
Jul 6, 2023 9:52am
BioNTech axes oral mRNA project after tech flunks early test
May 11, 2023 7:20am